EGFR (Epidermal Growth Factor Receptor) gene mutations are present in 10–40% of patients and are predominantly detected in female patients with adenocarcinoma, in non-smokers, and in Asian patients [7]. The gene discussed is EGFR; the disease is adenocarcinoma.